HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serologic response of gilts of breeding age to human influenza vaccines containing A/New Jersey/76 (HSW1N1) antigen.

Abstract
Twenty-four cross-bred gilts of breeding age were used in two studies to access the antigenic response to commercially produced human influenza vaccintes containing A/New Jersey/76 viral antigens. In experiments 1 only one of seven animals responded with an HI antibody titer of 1:40 or above. In the second experiment five of six gilts responded to higher dosages of vaccine with HI antibody titers of 1:40 or above. The positive titers persisted at least eighty-one days in two vaccinates in experiment 2.
AuthorsG T Woods, M E Mansfield
JournalResearch communications in chemical pathology and pharmacology (Res Commun Chem Pathol Pharmacol) Vol. 19 Issue 1 Pg. 177-80 (Jan 1978) ISSN: 0034-5164 [Print] United States
PMID625589 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
  • Antigens, Viral
  • Influenza Vaccines
Topics
  • Animals
  • Antibodies, Viral (analysis)
  • Antigens, Viral
  • Female
  • Humans
  • Influenza A virus (immunology)
  • Influenza Vaccines (adverse effects, pharmacology)
  • Swine (immunology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: